Assessment of the Quality of Reporting in Abstracts of Randomized Controlled Trials Published in Five Leading Chinese Medical Journals | PLOS ONE
CHINESE MEDICAL JOURNAL 影响因子6.100分,是几区,2022-2023年期刊投稿经验分享,CHINESE MEDICAL JOURNAL主页,推荐审稿人、编辑,审稿周期/时间,版面费多少,中国作者发表文章,修改意见
![The Lancet more than doubles its impact factor, eclipsing NEJM for the first time ever – Retraction Watch The Lancet more than doubles its impact factor, eclipsing NEJM for the first time ever – Retraction Watch](https://i0.wp.com/retractionwatch.com/wp-content/uploads/2022/06/lancet.jpeg?ssl=1)